A Pilot Study of Mitomycin, Ifosfamide and Cisplatin as Outpatient Combination Chemotherapy for Advanced Non-Small Cell Lung Cancer

Autor: Mariani, Gabriella Lucia, Pennucci, Maria Cristina, Addamo, Gianfranco, Venturini, Marco, Ardizzoni, Andrea, Rosso, Riccardo
Zdroj: Tumori Journal; December 1991, Vol. 77 Issue: 6 p511-513, 3p
Abstrakt: Twenty-one patients with advanced stage, non-small-cell lung carcinoma were treated with a chemotherapy regimen including: mitomycin (6 mg/m2), ifosfamide (3 g/m2), cisplatin (80 mg/m2). The regimen was administered on an outpatient basis. Two patients were lost to follow-up. Among the 29 patients evaluable for response we registered a response rate of 36.8 %; 36.8% of patients had stable disease, and 15.7 % progressed during treatment. Median duration was 8.7 months and median survival was 11 months. Toxicity was low and easily manageable on an outpatient basis.
Databáze: Supplemental Index